Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Accumulated Depreciation: 2023-2025

Historic Accumulated Depreciation for Upstream Bio (UPB) over the last 1 years, with Sep 2025 value amounting to $287,000.

  • Upstream Bio's Accumulated Depreciation rose 168.22% to $287,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $287,000, marking a year-over-year increase of 168.22%. This contributed to the annual value of $156,000 for FY2024, which is 132.84% up from last year.
  • Latest data reveals that Upstream Bio reported Accumulated Depreciation of $287,000 as of Q3 2025, which was up 19.09% from $241,000 recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's Accumulated Depreciation registered a high of $287,000 during Q3 2025, and its lowest value of $67,000 during Q4 2023.
  • Over the past 3 years, Upstream Bio's median Accumulated Depreciation value was $177,500 (recorded in 2024), while the average stood at $176,167.
  • Data for Upstream Bio's Accumulated Depreciation shows a peak YoY soared of 168.22% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Upstream Bio's Accumulated Depreciation stood at $67,000 in 2023, then spiked by 132.84% to $156,000 in 2024, then spiked by 168.22% to $287,000 in 2025.
  • Its Accumulated Depreciation stands at $287,000 for Q3 2025, versus $241,000 for Q2 2025 and $199,000 for Q1 2025.